SCHEMBL19863084

SCHEMBL19863084

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5c6oc7ccccc7c6cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c54)c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
TSHR P16473 5/20 0.35
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 5/20 0.33
POLB P06746 3/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
HPGD P15428 1/20 0.33
BRCA1 P38398 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863157 0.95 ALDH1A1 (0.37) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL18593779 0.94 ALDH1A1 (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL19863096 0.92 ALDH1A1 (0.33) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL19863082 0.92 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL19863086 0.92 MAPT (0.36) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL19863162 0.92 KDM4E (0.33) MAPTTSHRKDM4EHSD17B10ALDH1A1
SCHEMBL19863161 0.90 KDM4E (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL19863051 0.90 KDM4E (0.33) MAPTTSHRKDM4EHSD17B10ALDH1A1
SCHEMBL18594178 0.90 KDM4E (0.33) MAPTTSHRKDM4EHSD17B10ALDH1A1
SCHEMBL18594139 0.89 MAPT (0.37) MAPTTSHRLMNAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885LMNA 2975/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885LMNA 2975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.